In 2005, in a landmark paper viewed well over a million times, John Ioannidis explained in PLOS Medicine why most published research findings are false.
To coincide with PLOS Medicine’s 10th anniversary he responds to the challenge of this situation by suggesting how the research enterprise could be improved.
Research, including medical research, is subject to a range of biases which mean that misleading or useless work is sometimes pursued and published while work of value is ignored. The risks and rewards of academic careers, the structures and habits of peer reviewed journals, and the way universities and research institutions are set up and governed all have profound effects on what research scientists undertake, how they choose to do it and, ultimately, how patients are treated. Perverse incentives can lead scientists to waste time producing and publishing results which are wrong or useless. Understanding these incentives and altering them provides a potential way for drastically re-shaping research to improve in medical knowledge.
In a provocative and personal essay, designed to spur readers into thinking about how research careers could be redesigned in order to encourage better work, Ioannidis suggests practical ways in which our current situation could be improved. He describes how successful practices from some branches of science could be distributed to others which have performed badly, and suggests ways in which academic structures could provide greater benefits from the work of researchers, administrators, publishers and the research funding which supports them all.
The Latest on: Medical research
[google_news title=”” keyword=”medical research” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Medical research
- 288 years of serving New Orleans: Charity Hospital legacy endures at University Medical Center with new display and a tradition of careon May 11, 2024 at 9:59 pm
In May 1736, healthcare in New Orleans changed forever upon the opening of Charity Hospital. Founded by a grant from French sailor and shipbuilder Jean Louis, the hospital was dedicated ...
- New Clinical Trial Finds Faster Approach for Starting Extended-Release Naltrexone to Treat Opioid Use Disorder Shown Effectiveon May 11, 2024 at 6:49 am
New Clinical Trial Finds Faster Approach for Starting Extended-Release Naltrexone to Treat Opioid Use Disorder Shown Effective ...
- Why We Need More Black Women in Clinical Trialson May 10, 2024 at 10:05 am
Black Women remain underrepresented in clinical trials despite efforts of inclusion. Here's how that can change.
- Clinical trials aren’t the only way to get involved in sickle cell researchon May 10, 2024 at 7:01 am
Although columnist Mary Shaniqua is hesitant to join clinical trials, she's found another way to contribute to sickle cell research.
- Gladstone's Deepak Srivastava is using collaboration to propel medical researchon May 9, 2024 at 4:30 pm
Through the hardest of times Gladstone Institutes' president is focused on empowering medical research. Here's why Dr. Deepak Srivastava is one of our Most Admired CEOs.
- How Rochester medical research events will help you discover your ancestry, health riskson May 9, 2024 at 8:40 am
A series of federal medical research events in Rochester are seeking people willing to share their health story and information to aid the push to reduce health inequality in New York and across the ...
- Health care leaders plot how to expand diversity in clinical trialson May 9, 2024 at 8:28 am
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
- The Importance of Diversity in Medical Researchon May 8, 2024 at 5:00 pm
Medical research plays a crucial role in developing new treatments, understanding diseases, and improving overall health outcomes. However, the success of medical research depends heavily on the ...
- University of Minnesota professor's book investigates shocking medical research abuseon May 8, 2024 at 5:30 am
University of Minnesota philosophy professor Carl Elliott says that's not how it usually goes down. Elliott, whose book "The Occasional Human Sacrifice" is out next week, knows from experience.
- Introducing Cannovation Clinical Research Partners, LLC: Pioneering the Future of BioPharmaceutical Cannabinoid-Based Therapeuticson May 8, 2024 at 2:05 am
ATLANTA, GA / ACCESSWIRE / May 8, 2024 / Cannovation Clinical Research Partners, a pioneering Cannabis-Based Clinical Research Organization for Drug and Product Development, is proudly announcing its ...
via Bing News